Reference
Reiss S, et al. Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study. Neuro-Oncology 21 (Suppl. 6): vi232 abstr. RARE-51, Nov 2019. Available from: URL: http://doi.org/10.1093/neuonc/noz175.1194 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1797, 29 (2020). https://doi.org/10.1007/s40278-020-76536-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-76536-7